V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330001700 | 330000968 | 1.61 | 63.6 | Curative (C) | 2014-07-08 | 2014-07-16 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330005735 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001701 | 330000969 | 0 | 65.9 | Palliative (P) | 2016-09-26 | 2016-10-08 | Trial Unspecified | Y | N | 330005751 | TRIAL |
| 330001702 | 330000970 | 1.81 | 21.8 | Neo-adjuvant (N) | 2015-01-30 | 2015-02-13 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330005757 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001703 | 330000971 | 0 | 48 | Curative (C) | 2015-02-18 | 2015-02-21 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 330005768 | NOT MATCHED |
| 330001704 | 330000971 | 1.75 | 82 | Curative (C) | 2015-04-15 | 2015-04-15 | Cisplatin | N | Y | 330005768 | CISPLATIN |
| 330001705 | 330000972 | 1.6 | 66.1 | Curative (C) | 2016-09-18 | 2016-10-17 | Cisplatin | N | N | 330005773 | CISPLATIN |
| 330001706 | 330000972 | null | 65 | Neo-adjuvant (N) | 2016-08-18 | 2016-09-05 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330005773 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001707 | 330000973 | 1.5 | null | Curative (C) | 2014-10-13 | 2014-10-25 | Cisplatin 7 day | 02 | Y | 330005787 | CISPLATIN |
| 330001708 | 330000974 | 1.76 | 84.8 | Neo-adjuvant (N) | 2016-01-08 | 2016-01-08 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 330005788 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001709 | 330000975 | 1.51 | 12.4 | Neo-adjuvant (N) | null | 2015-09-09 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330005790 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001710 | 330000976 | 1.62 | 11.95 | Curative (C) | 2014-08-11 | 2014-08-11 | Cisplatin | 02 | N | 330005791 | CISPLATIN |
| 330001711 | 330000977 | 1.59 | 7.5 | null | null | 2017-12-25 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330005797 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001712 | 330006538 | 1.75 | 65 | Curative (C) | 2018-02-11 | 2018-02-20 | Cisplatin | N | N | 330005799 | CISPLATIN |
| 330001719 | 330000978 | 1.6 | 9.3 | Curative (C) | 2017-09-21 | 2017-09-21 | AML Interim Guidelines | null | N | 330005833 | NOT MATCHED |
| 330001720 | 330000979 | 1.78 | 34.1 | Palliative (P) | 2017-01-11 | 2017-01-12 | Trial Unspecified | N | N | 330005834 | TRIAL |
| 330001721 | 330000979 | 1.55 | 45.5 | Curative (C) | 2017-03-24 | 2017-04-22 | Cisplatin | null | N | 330005834 | CISPLATIN |
| 330001722 | 330000979 | null | 56.9 | Curative (C) | 2015-07-12 | 2015-08-05 | Cisplatin | 02 | Y | 330005834 | CISPLATIN |
| 330001723 | 330000980 | 0 | 67.8 | Curative (C) | 2017-04-14 | 2017-04-25 | EW EuroEwing 2012 Arm B VDC | Y | N | 330005848 | TRIAL |
| 330001724 | 330000980 | 1.7 | 8.9 | Curative (C) | 2017-01-17 | 2017-01-17 | EW EuroEwing 2012 Arm B VDC | Y | N | 330005848 | TRIAL |
| 330001725 | 330009533 | null | 48.3 | null | 2017-02-04 | 2017-02-26 | Cisplatin 7 day | N | Y | 330005856 | CISPLATIN |
| 330001726 | 330000981 | 0 | 62.1 | null | 2015-04-07 | 2015-04-08 | EW EuroEwing 2012 Arm B VDC | N | N | 330005860 | TRIAL |
| 330001727 | 330000982 | 1.79 | 80 | Curative (C) | 2014-06-29 | 2014-07-18 | Cisplatin 7 day | N | N | 330005861 | CISPLATIN |
| 330001728 | 330000983 | 1.77 | 70 | Neo-adjuvant (N) | 2014-02-06 | 2014-02-07 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | N | 330005865 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001729 | 330000984 | 1.84 | 0 | Palliative (P) | 2015-04-18 | 2015-04-18 | EW EuroEwing 2012 Arm B VDC | null | Y | 330005868 | TRIAL |
| 330001730 | 330000985 | 1.8 | 90.6 | Curative (C) | 2013-10-28 | 2013-11-23 | Cisplatin 7 day | N | N | 330005873 | CISPLATIN |
| 330001731 | 330000986 | null | 69.6 | Curative (C) | 2016-12-04 | 2016-12-15 | Cisplatin 7 day | null | Y | 330005877 | CISPLATIN |
| 330001732 | 330000987 | 0 | 83.7 | Curative (C) | 2013-09-06 | 2013-09-09 | Trial Unspecified | N | null | 330005881 | TRIAL |
| 330001733 | 330000987 | 1.71 | 81 | Curative (C) | 2013-08-20 | 2013-08-21 | NB HRNBL-1 COJEC Ind COURSE A | Y | Y | 330005881 | NOT MATCHED |
| 330001734 | 330000988 | 1.62 | 58 | Radical (R) | null | 2017-07-12 | Cisplatin | N | N | 330005883 | CISPLATIN |
| 330001735 | 330000988 | 1.7 | 17 | Neo-adjuvant (N) | 2016-10-23 | 2016-11-05 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 330005883 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001736 | 330000988 | 1.67 | 87 | Neo-adjuvant (N) | 2017-04-03 | 2017-04-09 | LI-1 TRIAL | Y | N | 330005883 | TRIAL |
| 330001737 | 330000989 | 1.71 | 65.5 | Curative (C) | 2013-08-16 | 2013-09-16 | Cisplatin 7 day | null | Y | 330005889 | CISPLATIN |
| 330001738 | 330000990 | 1.68 | 63.2 | Neo-adjuvant (N) | 2017-11-30 | 2017-12-07 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330005891 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001739 | 330000991 | 0 | 62.1 | Curative (C) | 2016-05-04 | 2016-05-04 | Trial Unspecified | Y | null | 330005896 | TRIAL |
| 330001740 | 330000991 | 1.73 | 9.1 | Neo-adjuvant (N) | null | 2015-02-01 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 330005896 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001741 | 330000992 | 1.69 | 57.7 | Curative (C) | 2015-09-22 | 2015-09-22 | Cisplatin | N | Y | 330005905 | CISPLATIN |
| 330001742 | 330000993 | 1.86 | 71.5 | Neo-adjuvant (N) | 2017-03-02 | 2017-03-22 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330005907 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001743 | 330000994 | 1.8 | null | Curative (C) | 2013-05-05 | 2013-05-07 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330005916 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001744 | 330000995 | null | 69.3 | Curative (C) | 2017-10-21 | 2017-11-04 | Cisplatin | N | Y | 330005919 | CISPLATIN |
| 330001745 | 330000996 | null | 13 | Curative (C) | 2017-10-09 | 2017-10-09 | NB Low/Interm risk guidelines Carbo/Etop | N | null | 330005922 | NOT MATCHED |
| 330001746 | 330000997 | 1.78 | 69 | Curative (C) | null | 2016-08-26 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330005925 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001747 | 330000998 | 1.59 | 62 | Curative (C) | 2015-05-21 | 2015-05-27 | Cisplatin | N | Y | 330005926 | CISPLATIN |
| 330001748 | 330000999 | 1.71 | null | Palliative (P) | 2015-12-25 | 2016-01-02 | EW EuroEwing 2012 Arm B VDC | N | N | 330005927 | TRIAL |
| 330001749 | 330000999 | null | 6.7 | Curative (C) | 2013-08-06 | 2013-08-06 | EW EuroEwing 2012 Arm B VDC | 01 | N | 330005927 | TRIAL |
| 330001750 | 330000999 | null | 3.4 | Neo-adjuvant (N) | 2015-06-17 | 2015-06-27 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330005927 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001752 | 330001001 | 1.7 | null | Curative (C) | 2017-02-11 | 2017-02-25 | Cisplatin 7 day | N | Y | 330005940 | CISPLATIN |
| 330001753 | 330001002 | 1.81 | 14 | Curative (C) | null | 2017-03-11 | Cisplatin | 02 | Y | 330005941 | CISPLATIN |
| 330001754 | 330001003 | null | 19.5 | Curative (C) | 2015-03-24 | 2015-03-24 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 330005944 | NOT MATCHED |
| 330001755 | 330001004 | 1.8 | 104 | Neo-adjuvant (N) | 2015-04-22 | 2015-04-22 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330005948 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001756 | 330006545 | 1.72 | 91.2 | Neo-adjuvant (N) | 2016-06-04 | 2016-06-05 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330005950 | CISPLATIN + DOCETAXEL + FLUOROURACIL |